Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Zaprinast

Zaprinast

Zaprinast structure

Zaprinast 

structure
  • CAS No:

    37762-06-4

  • Formula:

    C13H13N5O2

  • Chemical Name:

    Zaprinast

  • Synonyms:

    7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one,3,6-dihydro-5-(2-propoxyphenyl)-;7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one,1,4-dihydro-5-(2-propoxyphenyl)-;3,6-Dihydro-5-(2-propoxyphenyl)-7H-1,2,3-triazolo[4,5-d]pyrimidin-7-one;8-Aza-2-(2-propoxyphenyl)-6-purinone;2-(o-Propoxyphenyl)-8-azapurin-6-one;M&B 22,948;M and B 22948;Zaprinast;2-(2-Propoxyphenyl)-8-aza-6-purinone;5-(2-Propoxyphenyl)-1H-[1,2,3]triazolo[4,5-d]pyrimidin-7(4H)-one;M&B 22948;55122-20-8;68560-67-8

  • Categories:

    Active Pharmaceutical Ingredients  >  Antiallergic Drugs

Description

Zaprinast (M&B 22948) is an inhibitor of cGMP-selective Phosphodiesterases(PDEs)[1]. Zaprinast is a G protein-coupled receptor (GPR) 35 agonist which activates rat GPR35 strongly and activates human GPR35 moderately[2]. Zaprinast reduces vessel remodeling through antiproliferative and proapoptotic effects[3].


5-(2-propoxyphenyl)-2,3-dihydrotriazolo[4,5-d]pyrimidin-7-one is a member of triazolopyrimidines.

Zaprinast Basic Attributes

271.27

271.27

253-655-1

GXT25D5DS0

757885

DTXSID8045224

Characteristics

87.4

0.17

white solid

1.484g/cm3

241 °C (decomp)

406.3±47.0 °C at 760 mmHg

199.5±29.3 °C

1.719

soluble to 100 mM in DMSO;45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.11 mg/mL

Store at RT

159.2 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

Safety Information

NONH for all modes of transport

3

36/37/38

26-36

XZ6157358

Xi

P261-P305 + P351 + P338

H315-H319-H335

|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)

2-(2-propoxyphenyl)-8-azapurin-6-one

Zaprinast Use and Manufacturing

A selective inhibitor of cyclic-GMP phosphodiesterase (PDE V, calmodulin insensitive). Since cGMP mediates the vasorelaxant action of nitric oxide, as well as the natriuretic and diuretic effect of atrial natriuretic factor (ANF) through the activation of PKG (cGMP dependent protein kinase), such inhibitors may display vasodilating, relaxant, and diuretic effects.These compounds may prove useful in treating hypertension and congestive heart failure.

Computed Properties

Molecular Weight:271.27
XLogP3:1.6
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:4
Exact Mass:271.10692467
Monoisotopic Mass:271.10692467
Topological Polar Surface Area:92.3
Heavy Atom Count:20
Complexity:400
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Zaprinast

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.